RU2369635C2 - Иммунизация рыб против вирусной инфекции - Google Patents
Иммунизация рыб против вирусной инфекции Download PDFInfo
- Publication number
- RU2369635C2 RU2369635C2 RU2005120158A RU2005120158A RU2369635C2 RU 2369635 C2 RU2369635 C2 RU 2369635C2 RU 2005120158 A RU2005120158 A RU 2005120158A RU 2005120158 A RU2005120158 A RU 2005120158A RU 2369635 C2 RU2369635 C2 RU 2369635C2
- Authority
- RU
- Russia
- Prior art keywords
- virus
- fish
- dna
- carp
- live attenuated
- Prior art date
Links
- 241000251468 Actinopterygii Species 0.000 title claims abstract description 242
- 230000009385 viral infection Effects 0.000 title claims description 6
- 238000002649 immunization Methods 0.000 title abstract description 16
- 241000700605 Viruses Species 0.000 claims abstract description 363
- 241000252233 Cyprinus carpio Species 0.000 claims abstract description 72
- 230000002238 attenuated effect Effects 0.000 claims abstract description 71
- 238000000034 method Methods 0.000 claims abstract description 62
- 239000000203 mixture Substances 0.000 claims abstract description 22
- 230000028993 immune response Effects 0.000 claims abstract description 10
- 230000001018 virulence Effects 0.000 claims abstract description 8
- 108020004414 DNA Proteins 0.000 claims description 109
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 56
- 201000010099 disease Diseases 0.000 claims description 55
- 229960005486 vaccine Drugs 0.000 claims description 46
- 208000015181 infectious disease Diseases 0.000 claims description 45
- 230000003612 virological effect Effects 0.000 claims description 27
- 230000003053 immunization Effects 0.000 claims description 26
- 210000002966 serum Anatomy 0.000 claims description 24
- 210000000234 capsid Anatomy 0.000 claims description 22
- 241001465754 Metazoa Species 0.000 claims description 12
- 238000001493 electron microscopy Methods 0.000 claims description 12
- 102000053602 DNA Human genes 0.000 claims description 11
- 238000004113 cell culture Methods 0.000 claims description 10
- 230000036039 immunity Effects 0.000 claims description 10
- 239000007924 injection Substances 0.000 claims description 10
- 238000002347 injection Methods 0.000 claims description 10
- 230000008569 process Effects 0.000 claims description 9
- 239000002245 particle Substances 0.000 claims description 8
- 238000009360 aquaculture Methods 0.000 claims description 6
- 244000144974 aquaculture Species 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 238000002955 isolation Methods 0.000 claims description 6
- 244000005700 microbiome Species 0.000 claims description 6
- 238000012545 processing Methods 0.000 claims description 6
- 230000002829 reductive effect Effects 0.000 claims description 6
- 230000002498 deadly effect Effects 0.000 claims description 5
- 235000013305 food Nutrition 0.000 claims description 5
- 208000036142 Viral infection Diseases 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 3
- 238000007747 plating Methods 0.000 claims description 2
- 238000005507 spraying Methods 0.000 claims description 2
- 238000000386 microscopy Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 abstract description 11
- 239000003814 drug Substances 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 210000004027 cell Anatomy 0.000 description 40
- 238000002360 preparation method Methods 0.000 description 26
- 210000001519 tissue Anatomy 0.000 description 25
- 108020005202 Viral DNA Proteins 0.000 description 17
- 239000002609 medium Substances 0.000 description 17
- 239000008055 phosphate buffer solution Substances 0.000 description 17
- 241000283973 Oryctolagus cuniculus Species 0.000 description 16
- 239000000427 antigen Substances 0.000 description 15
- 102000036639 antigens Human genes 0.000 description 15
- 108091007433 antigens Proteins 0.000 description 15
- 239000002671 adjuvant Substances 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 239000012634 fragment Substances 0.000 description 12
- 210000000056 organ Anatomy 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- 238000011282 treatment Methods 0.000 description 11
- 241001529453 unidentified herpesvirus Species 0.000 description 11
- 238000002474 experimental method Methods 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 8
- 230000000120 cytopathologic effect Effects 0.000 description 8
- 238000011534 incubation Methods 0.000 description 8
- 210000003734 kidney Anatomy 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 241000701959 Escherichia virus Lambda Species 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 241000701161 unidentified adenovirus Species 0.000 description 7
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 6
- 241000252210 Cyprinidae Species 0.000 description 6
- 238000009007 Diagnostic Kit Methods 0.000 description 6
- 238000002965 ELISA Methods 0.000 description 6
- 150000007513 acids Chemical class 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 6
- 229940088710 antibiotic agent Drugs 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 239000003550 marker Substances 0.000 description 6
- 239000002773 nucleotide Substances 0.000 description 6
- 125000003729 nucleotide group Chemical group 0.000 description 6
- 239000013612 plasmid Substances 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 238000005303 weighing Methods 0.000 description 6
- 241000252231 Cyprinus Species 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 239000013604 expression vector Substances 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 230000014509 gene expression Effects 0.000 description 5
- 210000002816 gill Anatomy 0.000 description 5
- 230000003308 immunostimulating effect Effects 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 108091008146 restriction endonucleases Proteins 0.000 description 5
- 241000252229 Carassius auratus Species 0.000 description 4
- 241000252230 Ctenopharyngodon idella Species 0.000 description 4
- 108010067770 Endopeptidase K Proteins 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 108010067390 Viral Proteins Proteins 0.000 description 4
- 239000011543 agarose gel Substances 0.000 description 4
- 239000003638 chemical reducing agent Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 239000012894 fetal calf serum Substances 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 229960001438 immunostimulant agent Drugs 0.000 description 4
- 239000003022 immunostimulating agent Substances 0.000 description 4
- 238000011081 inoculation Methods 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000017074 necrotic cell death Effects 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 238000003906 pulsed field gel electrophoresis Methods 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 238000002255 vaccination Methods 0.000 description 4
- 229960004854 viral vaccine Drugs 0.000 description 4
- LHEJDBBHZGISGW-UHFFFAOYSA-N 5-fluoro-3-(3-oxo-1h-2-benzofuran-1-yl)-1h-pyrimidine-2,4-dione Chemical compound O=C1C(F)=CNC(=O)N1C1C2=CC=CC=C2C(=O)O1 LHEJDBBHZGISGW-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 3
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- 241000252211 Carassius Species 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 241000700588 Human alphaherpesvirus 1 Species 0.000 description 3
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000269808 Sparus Species 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 230000002458 infectious effect Effects 0.000 description 3
- 239000007928 intraperitoneal injection Substances 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 3
- 229910052721 tungsten Inorganic materials 0.000 description 3
- 239000010937 tungsten Substances 0.000 description 3
- QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 2
- 241000710780 Bovine viral diarrhea virus 1 Species 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 241000557626 Corvus corax Species 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- 241001051708 Cyprinid herpesvirus 3 Species 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 241001522035 Ectocarpus siliculosus virus 1 Species 0.000 description 2
- 241000283086 Equidae Species 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 241000700586 Herpesviridae Species 0.000 description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- 241000598171 Human adenovirus sp. Species 0.000 description 2
- 241000340965 Human papillomavirus type 27 Species 0.000 description 2
- 241000720946 Hypophthalmichthys molitrix Species 0.000 description 2
- 241000252234 Hypophthalmichthys nobilis Species 0.000 description 2
- 206010024264 Lethargy Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 241000188845 Porcine adenovirus Species 0.000 description 2
- 241000407608 Porcine endogenous retrovirus C Species 0.000 description 2
- 108010059712 Pronase Proteins 0.000 description 2
- 208000035415 Reinfection Diseases 0.000 description 2
- 241000701026 Saimiriine alphaherpesvirus 1 Species 0.000 description 2
- 241000700584 Simplexvirus Species 0.000 description 2
- 241000701421 Spodoptera exigua multiple nucleopolyhedrovirus Species 0.000 description 2
- 241000701093 Suid alphaherpesvirus 1 Species 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 241000500379 Xestia c-nigrum granulovirus Species 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- PPBOKXIGFIBOGK-BDTUAEFFSA-N bvdv Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C1=CN=CN1 PPBOKXIGFIBOGK-BDTUAEFFSA-N 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 208000010932 epithelial neoplasm Diseases 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- -1 for example Substances 0.000 description 2
- 239000013505 freshwater Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 230000002519 immonomodulatory effect Effects 0.000 description 2
- 229940031551 inactivated vaccine Drugs 0.000 description 2
- 210000003292 kidney cell Anatomy 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 231100000518 lethal Toxicity 0.000 description 2
- 230000001665 lethal effect Effects 0.000 description 2
- 238000012792 lyophilization process Methods 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 238000004264 monolayer culture Methods 0.000 description 2
- 239000003471 mutagenic agent Substances 0.000 description 2
- 231100000707 mutagenic chemical Toxicity 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- VLEIUWBSEKKKFX-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O VLEIUWBSEKKKFX-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 108700025333 4'-azido-Phe(6)- herpes simplex virus H2 (6-15) Proteins 0.000 description 1
- NMUSYJAQQFHJEW-UHFFFAOYSA-N 5-Azacytidine Natural products O=C1N=C(N)N=CN1C1C(O)C(O)C(CO)O1 NMUSYJAQQFHJEW-UHFFFAOYSA-N 0.000 description 1
- NMUSYJAQQFHJEW-KVTDHHQDSA-N 5-azacytidine Chemical compound O=C1N=C(N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 NMUSYJAQQFHJEW-KVTDHHQDSA-N 0.000 description 1
- WOVKYSAHUYNSMH-RRKCRQDMSA-N 5-bromodeoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 description 1
- 206010000117 Abnormal behaviour Diseases 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 208000009663 Acute Necrotizing Pancreatitis Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- WOVKYSAHUYNSMH-UHFFFAOYSA-N BROMODEOXYURIDINE Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-UHFFFAOYSA-N 0.000 description 1
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- 241000701412 Baculoviridae Species 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 238000011537 Coomassie blue staining Methods 0.000 description 1
- 241000711573 Coronaviridae Species 0.000 description 1
- 241000256054 Culex <genus> Species 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 241000537219 Deltabaculovirus Species 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 241000408655 Dispar Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000710831 Flavivirus Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 241000701074 Human alphaherpesvirus 2 Species 0.000 description 1
- 241000701024 Human betaherpesvirus 5 Species 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 1
- 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 1
- 241000701372 Iridovirus Species 0.000 description 1
- 231100000111 LD50 Toxicity 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 206010060860 Neurological symptom Diseases 0.000 description 1
- 241001465800 Orgyia Species 0.000 description 1
- 238000010222 PCR analysis Methods 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 206010058096 Pancreatic necrosis Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 241000710799 Rubella virus Species 0.000 description 1
- 241000519995 Stachys sylvatica Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 108010003533 Viral Envelope Proteins Proteins 0.000 description 1
- 206010051511 Viral diarrhoea Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 210000004690 animal fin Anatomy 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 229960002756 azacitidine Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229950004398 broxuridine Drugs 0.000 description 1
- 238000012993 chemical processing Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 201000003740 cowpox Diseases 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 238000000635 electron micrograph Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 208000010824 fish disease Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 239000012520 frozen sample Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000028996 humoral immune response Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000010820 immunofluorescence microscopy Methods 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000021633 leukocyte mediated immunity Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000018883 loss of balance Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000003843 mucus production Effects 0.000 description 1
- 230000004719 natural immunity Effects 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 208000009928 nephrosis Diseases 0.000 description 1
- 231100001027 nephrosis Toxicity 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 1
- 229940047091 other immunostimulants in atc Drugs 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000009372 pisciculture Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000005084 renal tissue Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000000528 statistical test Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/00034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/00061—Methods of inactivation or attenuation
- C12N2710/00064—Methods of inactivation or attenuation by serial passage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/03—Herpetoviridae, e.g. pseudorabies virus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL15377503A IL153775A0 (en) | 2003-01-01 | 2003-01-01 | Immunizing fish against viral infection |
| IL153775 | 2003-01-01 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2005120158A RU2005120158A (ru) | 2006-01-20 |
| RU2369635C2 true RU2369635C2 (ru) | 2009-10-10 |
Family
ID=29798413
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2005120158A RU2369635C2 (ru) | 2003-01-01 | 2003-12-22 | Иммунизация рыб против вирусной инфекции |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7351527B2 (https=) |
| EP (1) | EP1578959B1 (https=) |
| JP (2) | JP4690049B2 (https=) |
| CN (1) | CN100535108C (https=) |
| AT (1) | ATE507286T1 (https=) |
| AU (1) | AU2003288510A1 (https=) |
| DE (1) | DE60336927D1 (https=) |
| DK (1) | DK1578959T3 (https=) |
| IL (2) | IL153775A0 (https=) |
| PL (1) | PL209978B1 (https=) |
| RU (1) | RU2369635C2 (https=) |
| WO (1) | WO2004061093A1 (https=) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2640346C1 (ru) * | 2016-08-11 | 2017-12-27 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Государственный аграрный университет Северного Зауралья" (ФГБОУ ВО ГАУ Северного Зауралья) | Способ антиоксидантной защиты мальков карпа |
| RU2662768C2 (ru) * | 2011-12-30 | 2018-07-31 | Гесвал с.а. | Рекомбинантный герпесвирус кои (khv) и вакцина для профилактики заболевания, вызываемого khv |
| RU2663244C2 (ru) * | 2013-03-15 | 2018-08-03 | Атлантиум Текнолоджиз Лтд. | Система и способ для инактивации вируса инфекционного панкреатического некроза (ipnv) посредством оптимизированного ультрафиолетового излучения |
| RU2813731C2 (ru) * | 2019-02-05 | 2024-02-16 | Фармак Ас | Новый коронавирус рыб |
| US12564626B2 (en) | 2018-12-21 | 2026-03-03 | Intervet Inc. | Serum free intracellular pathogen vaccine |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5109114B2 (ja) * | 2006-02-24 | 2012-12-26 | 国立大学法人三重大学 | 魚類抗体産生の新規検出法 |
| WO2007119279A1 (ja) * | 2006-04-13 | 2007-10-25 | National University Corporation Tokyo University Of Marine Science And Technology | コイヘルペスウイルス（ｋｈｖ）病用ｄｎａワクチン |
| JP5567244B2 (ja) * | 2006-06-06 | 2014-08-06 | 共立製薬株式会社 | 魚類ストレプトコッカス・ディスガラクティエを抗原とする不活化ワクチン |
| BRPI0816134A2 (pt) * | 2007-08-28 | 2015-07-28 | Université de Liège | Herpesvírus, sequência de dna, vetor, célula, vírus, método para produção de partículas infecciosas, partículas infecciosas, vacina, uso de herpesvírus ou da sequência de dna ou do vetor ou das partículas infecciosas, e, método para o tratamento preventivo e/ou terapêutico de uma doença. |
| EP2031065A1 (en) * | 2007-08-28 | 2009-03-04 | Université de Liège | A recombinant koi herpesvirus (KHV) or Cyprinid herpesvirus 3 (CyHV-3) and a vaccine for the prevention of a disease caused by KHV/CyHV-3 in Cyprinus carpio carpio or Cyprinus carpio koi |
| JP2010143860A (ja) * | 2008-12-19 | 2010-07-01 | Chisso Corp | タンパク質の安定化剤 |
| JP5462518B2 (ja) * | 2009-04-09 | 2014-04-02 | 公益財団法人ヒューマンサイエンス振興財団 | 抗体精製方法 |
| EP2487241A1 (en) | 2011-02-09 | 2012-08-15 | Westfälische Wilhelms-Universität Münster | RNAi agents and compositions useful as carp therapeutics |
| JP6406703B2 (ja) * | 2013-05-15 | 2018-10-17 | 国立研究開発法人水産研究・教育機構 | コイ科ヘルペスウイルス−２（Ｃｙｐｒｉｎｉｄｈｅｒｐｅｓｖｉｒｕｓ−２：ＣｙＨＶ−２）感染症用ワクチンおよびその製造方法、ならびにＣｙＨＶ−２ウイルス製造方法 |
| CN103430936A (zh) * | 2013-09-06 | 2013-12-11 | 中国水产科学研究院黑龙江水产研究所 | 一种用于鱼类基因组dna提取的鱼鳍组织的制备方法 |
| IL230970A0 (en) * | 2014-02-13 | 2014-09-30 | Univ Ramot | Tilapia virus vaccines |
| CN104774802B (zh) * | 2015-04-27 | 2017-12-08 | 上海海洋大学 | 银鲫鱼背鳍细胞系 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5780448A (en) * | 1995-11-07 | 1998-07-14 | Ottawa Civic Hospital Loeb Research | DNA-based vaccination of fish |
-
2003
- 2003-01-01 IL IL15377503A patent/IL153775A0/xx unknown
- 2003-12-22 DE DE60336927T patent/DE60336927D1/de not_active Expired - Lifetime
- 2003-12-22 PL PL376441A patent/PL209978B1/pl unknown
- 2003-12-22 CN CNB2003801080535A patent/CN100535108C/zh not_active Expired - Lifetime
- 2003-12-22 JP JP2004564397A patent/JP4690049B2/ja not_active Expired - Fee Related
- 2003-12-22 EP EP03780585A patent/EP1578959B1/en not_active Expired - Lifetime
- 2003-12-22 AT AT03780585T patent/ATE507286T1/de not_active IP Right Cessation
- 2003-12-22 WO PCT/IL2003/001097 patent/WO2004061093A1/en not_active Ceased
- 2003-12-22 RU RU2005120158A patent/RU2369635C2/ru not_active IP Right Cessation
- 2003-12-22 DK DK03780585T patent/DK1578959T3/da active
- 2003-12-22 AU AU2003288510A patent/AU2003288510A1/en not_active Abandoned
-
2005
- 2005-06-27 IL IL169412A patent/IL169412A/en active IP Right Grant
- 2005-06-30 US US11/170,793 patent/US7351527B2/en not_active Expired - Lifetime
-
2010
- 2010-08-20 JP JP2010185273A patent/JP2011024584A/ja not_active Withdrawn
Non-Patent Citations (1)
| Title |
|---|
| GILAD О. et al., "Initial characteristics of koi herpesvims and development of a polymerase chain reaction assay to detect the vims in koi, Cyprinus carpio koi", Dis Aquat Organ. 2002 Mar 11; 48(2):101-8. DATABASE ENTREZ NUCLEOTIDES 'Online! ncbi; 15.06.2007, AOKI T. et al.: "Genome sequences of three koi herpesvirus isolates representing the expanding distribution of an emerging disease threatening koi and common carp worldwide", Database accession no. NC-009127, 01:131840030, abstract. БЕЛОУСОВА P.B. и др. ВЕТЕРИНАРНАЯ ВИРУСОЛОГИЯ. - М.: Колос, 2007, с.191-193. * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2662768C2 (ru) * | 2011-12-30 | 2018-07-31 | Гесвал с.а. | Рекомбинантный герпесвирус кои (khv) и вакцина для профилактики заболевания, вызываемого khv |
| RU2663244C2 (ru) * | 2013-03-15 | 2018-08-03 | Атлантиум Текнолоджиз Лтд. | Система и способ для инактивации вируса инфекционного панкреатического некроза (ipnv) посредством оптимизированного ультрафиолетового излучения |
| RU2640346C1 (ru) * | 2016-08-11 | 2017-12-27 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Государственный аграрный университет Северного Зауралья" (ФГБОУ ВО ГАУ Северного Зауралья) | Способ антиоксидантной защиты мальков карпа |
| RU2818370C2 (ru) * | 2018-12-21 | 2024-05-02 | Интервет Интернэшнл Б.В. | Вакцина против внутриклеточного патогена, не содержащая сыворотки |
| US12564626B2 (en) | 2018-12-21 | 2026-03-03 | Intervet Inc. | Serum free intracellular pathogen vaccine |
| RU2813731C2 (ru) * | 2019-02-05 | 2024-02-16 | Фармак Ас | Новый коронавирус рыб |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003288510A8 (en) | 2004-07-29 |
| EP1578959A1 (en) | 2005-09-28 |
| AU2003288510A1 (en) | 2004-07-29 |
| DE60336927D1 (https=) | 2011-06-09 |
| ATE507286T1 (de) | 2011-05-15 |
| DK1578959T3 (da) | 2011-08-15 |
| JP2011024584A (ja) | 2011-02-10 |
| IL153775A0 (en) | 2003-07-31 |
| WO2004061093A1 (en) | 2004-07-22 |
| US20060013828A1 (en) | 2006-01-19 |
| JP2006512078A (ja) | 2006-04-13 |
| EP1578959B1 (en) | 2011-04-27 |
| CN1742083A (zh) | 2006-03-01 |
| IL169412A (en) | 2011-04-28 |
| PL376441A1 (en) | 2005-12-27 |
| US7351527B2 (en) | 2008-04-01 |
| JP4690049B2 (ja) | 2011-06-01 |
| PL209978B1 (pl) | 2011-11-30 |
| CN100535108C (zh) | 2009-09-02 |
| RU2005120158A (ru) | 2006-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011024584A (ja) | ウイルス感染に対する免疫魚 | |
| Saint-Jean et al. | Infectious pancreatic necrosis virus: biology, pathogenesis, and diagnostic methods | |
| Torres et al. | First field trial of a transmissible recombinant vaccine against myxomatosis and rabbit hemorrhagic disease | |
| Krametter‐Frötscher et al. | Serological survey for antibodies against pestiviruses in sheep in Austria | |
| Borie et al. | Microbiological hazards related to xenotransplantation of porcine organs into man | |
| Conraths et al. | Bluetongue disease: an analysis of the epidemic in Germany 2006–2009 | |
| Lavazza et al. | How many caliciviruses are there in rabbits? A review on RHDV and correlated viruses | |
| Savini et al. | Monovalent modified-live vaccine against bluetongue virus serotype 2: immunity studies in cows. | |
| AU2002253542B2 (en) | Purified subfragment encoding neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis | |
| CN118480515B (zh) | 一种猪繁殖与呼吸综合征病毒nadc30病毒株及其应用 | |
| Frölich et al. | European brown hare syndrome | |
| Garland et al. | Attempts to infect pigs with coxsackie virus type B5 | |
| CN105866424B (zh) | 一种鸭坦布苏病毒病疫苗的效力检验方法 | |
| CN100384988C (zh) | 2型鸡星状病毒 | |
| Abd El-Ghany | Forms of avian reovirus in poultry production: An overview | |
| Goswami et al. | A review on lumpy skin disease: one of the most neglected diseases of cattle with an unprecedented incidence in non-endemic countries | |
| JPH02295934A (ja) | イヌコロナウイルスワクチン | |
| Chandra et al. | Haemorrhagic enteritis of turkeys and related infections of pheasants and domestic fowl: a review | |
| CN118931848B (zh) | 一种猪圆环病毒3型病毒株及其应用 | |
| KR102912905B1 (ko) | 닭전염성빈혈증 바이러스 감염 예방을 위한 백신 조성물 | |
| JP4785531B2 (ja) | マーカーワクチンとしてのニューカッスル病ウイルスのエスケープミュータント | |
| KR100391265B1 (ko) | 흑염소 로타 바이러스 순화주, 이의 제조 방법 및 용도 | |
| KWONG | Vaccination Efficacies against Myxomatosis | |
| Mukiibi-Muka | Studies on local and systemic antibody responses in chicken to avian reovirus infections. | |
| Siddiqui et al. | A comprehensive overview of infectious bursal disease, a major threat to poultry health and production |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20131223 |